Latest & greatest articles for schizophrenia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on schizophrenia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on schizophrenia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for schizophrenia

1. Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia

Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia - Repository of AIHTA GmbH English | Browse - - - Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia Gassner, L. and Mayer-Ferbas, J. (2020): Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia (...) , Depression, Insomnia and Schizophrenia. HTA-Projektbericht 133. Preview - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. , oder 1MB Abstract Introduction: Music therapy is an expression promoting, scientific-artistic-creative and independent form of treatment and aims at maintaining, restoring, and furthering physical, emotional, and mental health. This systematic review aims at assessing the effectiveness of music therapy for the treatment of autism spectrum disorder, dementia

2020 Austrian Institute of Health Technology Assessment

2. Assessing the efficacy and feasibility of providing metacognitive training for patients with schizophrenia by mental health nurses: A randomized controlled trial

Assessing the efficacy and feasibility of providing metacognitive training for patients with schizophrenia by mental health nurses: A randomized controlled trial Assessing the efficacy and feasibility of providing metacognitive training for patients with schizophrenia by mental health nurses: A randomized controlled trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) Actions . 2020 Nov 22. doi: 10.1111/jan.14627. Online ahead of print. Assessing the efficacy and feasibility of providing metacognitive training for patients with schizophrenia by mental health nurses: A randomized controlled trial , , , , , Affiliations Expand Affiliations 1 University of Évora, Évora, Portugal. 2 Comprehensive Health Research Centre (CHRC), Évora, Portugal. 3 Universitat Rovira and Virgili, Tarragona, Spain. 4 School of Nursing of Porto, Porto, Portugal. 5 NursID - Innovation

2020 EvidenceUpdates

3. The Impacts of Parental Schizophrenia on the Psychosocial Well-Being of Offspring: A Systematic Review Full Text available with Trip Pro

The Impacts of Parental Schizophrenia on the Psychosocial Well-Being of Offspring: A Systematic Review The Impacts of Parental Schizophrenia on the Psychosocial Well-Being of Offspring: A Systematic Review | IntechOpen Submit Open Access is an initiative that aims to make scientific research freely available to all. To date our community has made over 100 million downloads. It’s based on principles of collaboration, unobstructed discovery, and, most importantly, scientific progression. As PhD (...) access peer-reviewed chapter The Impacts of Parental Schizophrenia on the Psychosocial Well-Being of Offspring: A Systematic Review By Sabreena Hussain Submitted: November 26th 2019 Reviewed: February 7th 2020 Published: April 28th 2020 DOI: 10.5772/intechopen.91658 > > Downloaded: 162 Edited by Floriana Irtelli, Federico Durbano and Simon George Taukeni 1. Introduction Schizophrenia is a type of ‘psychosis’ which causes individuals to experience distressing symptoms [ ] such as the lack of ability

2020 Quality of Life - Biopsychosocial Perspectives

4. Semantic memory impairment across the schizophrenia continuum: a meta-analysis of category fluency performance Full Text available with Trip Pro

Semantic memory impairment across the schizophrenia continuum: a meta-analysis of category fluency performance Validate User We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will take you to your content. Could not validate captcha. Please try again. Take me to my Content

2020 Schizophrenia Bulletin Open

5. Efficacy of psychological treatments for patients with schizophrenia and relevant negative symptoms: A meta-analysis Full Text available with Trip Pro

Efficacy of psychological treatments for patients with schizophrenia and relevant negative symptoms: A meta-analysis Efficacy of Psychological Treatments for Patients With Schizophrenia and Relevant Negative Symptoms: A Meta-Analysis| Clinical Psychology in Europe Quick jump to page content | Search Published at 30. September 2020 Issue: Section: Systematic Reviews and Meta-analyses Keywords: schizophrenia and psychosis negative symptoms psychotherapy nonpharmacological treatment meta-analysis (...) Share: Riehle, M., Böhl, M. C., Pillny, M., & Lincoln, T. M. (2020). Efficacy of Psychological Treatments for Patients With Schizophrenia and Relevant Negative Symptoms: A Meta-Analysis. Clinical Psychology in Europe , 2 (3), 1-23. https://doi.org/10.32872/cpe.v2i3.2899 More Citation Formats Download Citation This work is licensed under a PlumX Dimensions Views: Total Abstract PDF HTML XML 1005 601 338 55 11 Downloads: Download data is not yet available. Riehle M., Böhl M. C., Pillny M., Lincoln T

2020 Clinical Psychology in Europe

6. Maintenance treatment with antipsychotic drugs for schizophrenia. (Abstract)

Maintenance treatment with antipsychotic drugs for schizophrenia. The symptoms and signs of schizophrenia have been linked to high levels of dopamine in specific areas of the brain (limbic system). Antipsychotic drugs block the transmission of dopamine in the brain and reduce the acute symptoms of the disorder. An original version of the current review, published in 2012, examined whether antipsychotic drugs are also effective for relapse prevention. This is the updated version of the aforesaid (...) review.To review the effects of maintaining antipsychotic drugs for people with schizophrenia compared to withdrawing these agents.We searched the Cochrane Schizophrenia Group's Study-Based Register of Trials including the registries of clinical trials (12 November 2008, 10 October 2017, 3 July 2018, 11 September 2019).We included all randomised trials comparing maintenance treatment with antipsychotic drugs and placebo for people with schizophrenia or schizophrenia-like psychoses.We extracted data

2020 Cochrane

7. The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis Full Text available with Trip Pro

The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints (...) . The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis Yongping Liu, Xue Wu, Xi Xia, Jun Yao, Bao-jie Wang Yongping Liu China Medical University Xue Wu China Medical University Xi Xia China Medical University Jun Yao China Medical University

2020 Research Square

8. Paliperidone - maintenance treatment of schizophrenia

Paliperidone - maintenance treatment of schizophrenia Official address Domenico Scarlattilaan 6 ? 1083 HS Amsterdam ? The Netherlands An agency of the European Union Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 © European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged. EMA/277302/2020 EMEA/H/C/005486 Paliperidone Janssen-Cilag International (...) (paliperidone) An overview of Paliperidone Janssen-Cilag International and why it is authorised in the EU What is Paliperidone Janssen-Cilag International and what is it used for? Paliperidone Janssen-Cilag International is an antipsychotic medicine used for the maintenance treatment of schizophrenia in adults whose disease has already been stabilised on treatment with paliperidone or risperidone. Some patients whose symptoms have not yet been stabilised may still be given Paliperidone Janssen- Cilag

2020 European Medicines Agency - EPARs

9. eHealth tools for assessing psychomotor activity in schizophrenia: a systematic review Full Text available with Trip Pro

focusing on schizophrenia diagnosis. The following search terms were used (in any field): ((ehealth OR mhealth OR technology OR actigraph OR phone OR app OR virtual reality OR video game OR videogame OR wearables OR computer) AND (psychomotor OR movement OR motor OR mobility OR physical activity) AND (schizophrenia OR psychosis OR psychotic OR schizophrenic)). The references of included studies were also screened. Study selection process The publications were assessed independently by two researchers (...) eHealth tools for assessing psychomotor activity in schizophrenia: a systematic review eHealth tools for assessing psychomotor activity in schizophrenia: a systematic review Services on Demand Journal Article Indicators Cited by SciELO Related links Similars in SciELO Share Print version ISSN 1516-4446 On-line version ISSN 1809-452X Braz. J. Psychiatry, ahead of print Epub June 15, 2020 REVIEW ARTICLE eHealth tools for assessing psychomotor activity in schizophrenia: a systematic review Rosa

2020 Brazilian Journal of Psychiatry

10. Avatar Therapy for people with schizophrenia or related disorders. (Abstract)

Avatar Therapy for people with schizophrenia or related disorders. Many people with schizophrenia do not achieve satisfactory improvements in their mental state, particularly the symptom of hearing voices (hallucinations), with medical treatment.To examine the effects of Avatar Therapy for people with schizophrenia or related disorders.In December 2016, November 2018 and April 2019, the Cochrane Schizophrenia Group's Study-Based Register of Trials (including registries of clinical trials (...) ) was searched, review authors checked references of all identified relevant reports to identify more studies and contacted authors of trials for additional information.All randomised clinical trials focusing on Avatar Therapy for people with schizophrenia or related disorders.We extracted data independently. For binary outcomes, we calculated risk ratio (RR) and 95% confidence intervals (CI), on an intention-to-treat basis. For continuous data, we estimated the mean difference (MD) between groups and 95

2020 Cochrane

11. Effectiveness of Community-Based Interventions for Patients with Schizophrenia: A Study Protocol for a Systematic Review Full Text available with Trip Pro

Effectiveness of Community-Based Interventions for Patients with Schizophrenia: A Study Protocol for a Systematic Review Effectiveness of Community-Based Interventions for Patients with Schizophrenia: A Study Protocol for a Systematic Review | Research Square Browse Tools & Services Your Cart This preprint is under consideration at Systematic Reviews . A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer (...) review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Protocol Effectiveness of Community-Based Interventions for Patients with Schizophrenia: A Study Protocol for a Systematic Review Soo-yeon Kim, Ah Rim Kim Soo-yeon Kim Daegu Haany University Corresponding Author Ah Rim Kim Far East University DOI: License: This work

2020 Research Square

12. The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis Full Text available with Trip Pro

The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints (...) . The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis Yongping Liu, Xue Wu, Xi Xia, Jun Yao, Bao-jie Wang Yongping Liu China Medical University Xue Wu China Medical University Xi Xia China Medical University Jun Yao China Medical University

2020 Research Square

13. A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia. (Abstract)

A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia. An oral compound, SEP-363856, that does not act on dopamine D2 receptors but has agonist activity at trace amine-associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A (5-HT1A) receptors, may represent a new class of psychotropic agent for the treatment of psychosis in schizophrenia.We performed a randomized, controlled trial to evaluate the efficacy and safety of SEP-363856 in adults with an acute exacerbation (...) of schizophrenia. The patients were randomly assigned in a 1:1 ratio to receive once-daily treatment with SEP-363856 (50 mg or 75 mg) or placebo for 4 weeks. The primary end point was the change from baseline in the total score on the Positive and Negative Symptom Scale (PANSS; range, 30 to 210; higher scores indicate more severe psychotic symptoms) at week 4. There were eight secondary end points, including the changes from baseline in the scores on the Clinical Global Impressions Severity (CGI-S) scale

2020 NEJM

14. Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial Full Text available with Trip Pro

Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information (...) for Treatment of Schizophrenia: A Randomized Clinical Trial , , , , , , , , , Affiliations Expand Affiliations 1 Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York. 2 Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, New York. 3 Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany. 4 Intra-Cellular Therapies Inc, New York, New York. 5 Now with Axsome Therapeutics Inc, New York, New

2020 EvidenceUpdates

15. No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studies Full Text available with Trip Pro

No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studies No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studies | Research Square Browse Tools & Services Your Cart This preprint is under consideration at BMC Medical Genetics . A preprint is a preliminary version of a manuscript that has not completed peer (...) review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studies Xiao-na Li, Ji-long Zheng, Xiao-han Wei, Bao

2020 Research Square

16. A meta-analysis of the association between RGS4 gene polymorphisms and schizophrenia Full Text available with Trip Pro

A meta-analysis of the association between RGS4 gene polymorphisms and schizophrenia A meta-analysis of the association between RGS4 gene polymorphisms and schizophrenia | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its (...) validity or suitability for dissemination as established information or for guiding clinical practice. Research article A meta-analysis of the association between RGS4 gene polymorphisms and schizophrenia Feng-ling Xu, Xue Wu, Li Liu, Xi Xia, Ya Li, Jun Yao, Bao-jie Wang Feng-ling Xu China Medical University Xue Wu China Medical University Li Liu First Hospital of China Medical University Xi Xia China Medical University Ya Li China Medical University Jun Yao China Medical University Bao-jie Wang China

2020 Research Square

17. Psychosocial Family Interventions for Relatives of People Living with Schizophrenia in the Arab World: Systematic Review Full Text available with Trip Pro

Psychosocial Family Interventions for Relatives of People Living with Schizophrenia in the Arab World: Systematic Review Psychosocial Family Interventions for Relatives of People Living with Schizophrenia in the Arab World: Systematic Review | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior (...) to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Psychosocial Family Interventions for Relatives of People Living with Schizophrenia in the Arab World: Systematic Review Aziza Saleh Al Sawafi, Karina Lovell, Laoise Renwick, Nusrat Husain Aziza Saleh Al Sawafi Sultan Qaboos University Corresponding Author ORCiD: https

2020 Research Square

18. The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an update meta-analysis Full Text available with Trip Pro

The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an update meta-analysis The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an update meta-analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints (...) . The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an update meta-analysis Yongping Liu, Xue Wu, Xi Xia, Jun Yao, Bao-jie Wang Yongping Liu China Medical University Xue Wu China Medical University Xi Xia China Medical University Jun Yao China Medical University Bao

2020 Research Square

19. No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studies Full Text available with Trip Pro

No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studies No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studies | Research Square Browse Tools & Services Your Cart This preprint is under consideration at BMC Medical Genetics . A preprint is a preliminary version of a manuscript that has not completed peer (...) review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studies Xiao-na Li, Ji-long Zheng, Xiao-han Wei, Bao

2020 Research Square

20. Treatment of Patients with Schizophrenia

Treatment of Patients with Schizophrenia This guideline is undergoing copyediting and the final version is expected to be released summer 2020. THE AMERICAN PSYCHIATRIC ASSOCIATION PRACTICE GUIDELINE FOR THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA Guideline Writing Group George A. Keepers, M.D. (Chair) Laura J. Fochtmann, M.D., M.B.I. (Vice-Chair; Methodologist) Joan M. Anzia, M.D. Sheldon Benjamin, M.D. Jeffrey M. Lyness, M.D. Ramin Mojtabai, M.D. Mark Servis, M.D. Art Walaszek, M.D. Peter (...) Schizophrenia 18 Implementation 18 Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement 31 Review of Available Guidelines from Other Organizations 32 Quality Measurement Considerations 32 Statement 2: Use of Quantitative Measures 33 Implementation 33 Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement 36 Review of Available Guidelines from Other Organizations 38 Quality Measurement Considerations 38 Statement 3: Evidence-based

2020 American Psychiatric Association